Clinical Trials Directory

Trials / Completed

CompletedNCT01575236

A Randomized Non Crossover Study of the GuardianTM Versus SupremeTM Laryngeal Mask Airway

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Schulthess Klinik · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the GuardianTM and the LMA SupremeTM in paralyzed, anesthetized patients.

Detailed description

The GuardianTM is a new extraglottic airway device which brings together features of both the LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate ventilation, airway protection and airway obstruction, respectively) and the LMA UniqueTM (single use - prevention of disease transmission). In the following randomized, non-crossover study, the investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the GuardianTM and the LMA SupremeTM in paralyzed, anesthetized patients.

Conditions

Interventions

TypeNameDescription
DEVICEGuardian Laryngeal Maskease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric insertion
DEVICESupreme Laryngeal Mask Airwayease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric insertion

Timeline

Start date
2012-03-01
Primary completion
2012-06-01
Completion
2012-07-01
First posted
2012-04-11
Last updated
2012-08-08

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01575236. Inclusion in this directory is not an endorsement.